Direct Acting Antivirals Impact on Biochemical, Immunological and Hematological Responses in HCV Infected Patients

Effect of Treatment of Hepatitis C by Directly Acting Antivirals (DAA) on Chronic Hepatitis C, B Coinfected Patients

Impact of Treatment of Chronic HCV Patients by Direct Acting Antiviral Drugs (DAADs) on COVID -19 Disease Frequency and Severity

Impact of Hepatitis C virus Infection and direct-acting Oral Antiviral Drugs on glycaemic state in Type 2 Diabetic Patients

Cognitive Impairment, Extrapyramidal Manifestations, and their impact on Quality of Life in Patients with HCV-Related Chronic Liver Diseases

Quality of Life among Hepatitis C Virus Patients Undergoing Direct Acting Antivirals

Assessment of Cerebrovascular and Cognitive Changes in Chronic Hepatitis C Patients

Assessment of Executive Functions in Chronic Hepatitis C Virus Infected Patients

IMPACT OF DIABETIC CONTROL ON ACHIEVING SUSTAINED VIROLOGIC RESPONSE IN CHRONIC HCV PATIENTS RECEIVING DIRECT-ACTING ANTIVIRALS

Effect of Direct Acting Anti-viral Agents on Insulin Resistance in Chronic HCV Patients